Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xueguan Lu
Observed names:
Lu, Xue-Guan,
Lu, Xueguan
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center,
Shanghai Clinical Research Center
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center,
Shanghai Clinical Research Center
ORCID:
0000-0001-9829-3312
Observed ORCID:
0000-0001-9829-3312
OpenAlex ID:
A5019043458
Efficacy and safety of STUPP regimen with or without anlotinib for newly diagnosed glioblastoma: Results of a multicenter, double-blind, randomized phase II trial.
2025
·
Yuanyuan Chen
, Guihong Liu
, et al.
·
Journal of Clinical Oncology
·
3
PDF
Camrelizumab combined with cetuximab and chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): 1-year outcomes from the phase II trial.
2025
·
Dongmei Ji
, Youzhou Sang
, et al.
·
Journal of Clinical Oncology
·
1
PDF
Preliminary efficacy and safety of camrelizumab combined with cetuximab and chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): A phase II clinical trial.
2024
·
Dongmei Ji
, Youzhou Sang
, et al.
·
Journal of Clinical Oncology
·
1
PDF
The impact of induction chemotherapy response to survival outcomes in oropharyngeal cancer.
2022
·
Qixian Zhang
, Xin Zhou
, et al.
·
Journal of Clinical Oncology
·
1
Postoperative radiotherapy with concomitant temozolomide plus anlotinib for newly diagnosed glioblastoma: Study protocol for a multicenter, double-blind, randomized phase II trial
2022
·
Yuanyuan Chen
, Baiqiang Dong
, et al.
·
Glioma
·
1
Biomarker-Stratified Phase II Trial of Trastuzumab Rezetecan in Advanced Salivary Gland Carcinoma Across Cohorts With High and Low Human Epidermal Growth Factor Receptor 2 Expression
2026
·
Guang-Liang Chen
, Yanjing Guo
, et al.
·
Journal of Clinical Oncology
Subsite-specific benefit of induction chemoimmunotherapy in HPV-negative oropharyngeal squamous cell carcinoma
2026
·
Lin Zhu
, Die Zhang
, et al.
·
Frontiers in Oncology
PDF
Clinicopathological analysis and therapeutic management of radiation-induced sarcomas of the head and neck: A single-center retrospective study.
2026
·
Xin Liu
, Yanjing Guo
, et al.
·
Journal of Clinical Oncology
ctDNA as a complement to gene-expression–based site prediction to guide therapy in cancer of unknown primary: Results from Fudan CUP-001.
2026
·
Xin Liu
, Shiyu Jiang
, et al.
·
Journal of Clinical Oncology
PDF
Phase III randomized trial of tislelizumab plus gemcitabine/capecitabine (GX) versus tislelizumab plus gemcitabine/cisplatin (GP) as first-line therapy for recurrent/metastatic nasopharyngeal carcinoma: A prospective multicenter study (PROGRESS).
2026
·
Dongmei Ji
, Yanan Yang
, et al.
·
Journal of Clinical Oncology
PDF
Validation of the 9th edition cTNM classification for HPV-positive oropharyngeal carcinoma in a non-endemic Chinese cohort
2026
·
Wenjiao Lv
, Die Zhang
, et al.
·
Clinical and Translational Radiation Oncology
PDF
Induction toripalimab plus chemotherapy followed by selective chemoradiation de-escalation in HPV-positive oropharyngeal cancer: a single-arm, phase 2 trial (IChoice-02)
2026
·
Xueguan Lu
, Xin Zhou
, et al.
·
Radiotherapy and Oncology
Anatomic distribution of local recurrence of nasopharyngeal carcinoma in the Era of IMRT: Suggestion of modification of clinical target volume delineation.
2022
·
Xiaomin Ou
, Jiazhou Wang
, et al.
·
Journal of Clinical Oncology
Selective treatment de-intensification with reduced-dose radiation and omitted concurrent chemotherapy guided by response to induction chemotherapy in HPV-associated oropharyngeal squamous cell carcinoma: A single-arm, phase II trial (IChoice-01).
2022
·
Xueguan Lu
, Tingting Xu
, et al.
·
Journal of Clinical Oncology
A Ten-year Experience of the Multidisciplinary Management of the Regional Failure of Nasopharyngeal Carcinoma in the Era of IMRT
2020
·
xiyin Guan
, Xing Xing
, et al.
·
Research Square
PDF
Show more works
View as search
Works count:
27
Citation count:
7
H-index:
1
I10-index:
Year
Topic
Type